Opyl Ltd. (AU:OPL) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Opyl Limited has issued 200,000 fully paid ordinary shares without investor disclosure requirements, adhering to compliance guidelines under the Corporations Act. As a forward-thinking AI company, Opyl is focused on revolutionizing clinical trials and medical research, aligning with its strategic growth objectives.
For further insights into AU:OPL stock, check out TipRanks’ Stock Analysis page.